Skip to Main Content

Author Details

Sujun Chen
Princess Margaret Cancer Center/University Health Network
2014
33
18
PMIDPaper TitleJournal TitlePublished Year
36997534MYC reshapes CTCF-mediated chromatin architecture in prostate cancer.Nat Commun2023
37549269SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1.Proc Natl Acad Sci U S A2023
37478850Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer.Cancer Cell2023
37478845A lncRNA from the FTO locus acts as a suppressor of the m<sup>6</sup>A writer complex and p53 tumor suppression signaling.Mol Cell2023
37692852Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool.Front Oncol2023
34740924Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.Clin Cancer Res2022
36309516The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.Nat Commun2022
36129942CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer.Proc Natl Acad Sci U S A2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
33420488Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.Nat Cell Biol2021
33741908CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer.Nat Commun2021
34075878HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.Elife2021
32868907Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.Nat Genet2020
32938917Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes.Nat Commun2020
32963597Differential expression of peptides serves as an indicator of IgA nephropathy in pediatric patients.Exp Ther Med2020
30655535ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019
31324883Forkhead domain mutations in FOXA1 drive prostate cancer progression.Cell Res2019
31623872Landscape of Noncoding RNA in Prostate Cancer.Trends Genet2019
31444154ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate Cancer.Cancer Res2019
30735634Widespread and Functional RNA Circularization in Localized Prostate Cancer.Cell2019
31032301Orphan noncoding RNAs: novel regulators and cancer biomarkers.Ann Transl Med2019
30718921TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells.Oncogene2019
29340374A well-defined unimolecular channel facilitates chloride transport.Chem Commun (Camb)2018
29937226LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.Cell2018
30033362Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.Cell2018
30445811An Artificial Molecular Shuttle Operates in Lipid Bilayers for Ion Transport.J Am Chem Soc2018
29552290ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells.Oncotarget2018
28289232Transcriptional landscape of the human cell cycle.Proc Natl Acad Sci U S A2017
28383547G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.Cell Death Dis2017
27058897KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.Oncotarget2016
27761537Oligo(aryl-triazole)s CHCl<sup>-</sup> interactions guide chloride efficient and selective transmembrane transport.Chem Commun (Camb)2016
27716038ChiLin: a comprehensive ChIP-seq and DNase-seq quality control and analysis pipeline.BMC Bioinformatics2016
25369933Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.Proc Natl Acad Sci U S A2014
  • 1 - 33 of 33

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 9
Mohammed Kanchwala
The University of Texas Southwestern Medical Center
Career Start Year 2016
Number of shared co-authors 3
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 11
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 9
Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 8
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 12
Jin-Yih Low
Fred Hutchinson Cancer Center
Career Start Year 2010
Number of shared co-authors 8
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 12
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 26
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 16
John R Prensner
University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 19
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 31
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 26
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 3
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 9
Amy G Robertson
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 6
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 6
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 15
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 13
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 7
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 12
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 27
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 6
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 11
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 13
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 56
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 38

Collaborators

Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 23
Junjie T Hua
School of Public Health, Sun Yat-sen University
Co-authored papers 8
Musaddeque Ahmed
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
Fraser Soares
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
Paul C Boutros
University of California los angeles
Co-authored papers 6
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 6
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers 5
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 5
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Shuai Gao
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Co-authored papers 5
Changmeng Cai
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Co-authored papers 5
Wanting Han
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Co-authored papers 4
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Xiaole Shirley Liu
Co-authored papers 4
Yong Zeng
College of Life Science, Hunan Normal University
Co-authored papers 4
Amina Zoubeidi
University of British Columbia
Co-authored papers 4
Fan Zhang
Huaihe Hospital of Henan University
Co-authored papers 3
Yue Yang
Institute of Cancer Prevention and Treatment, Harbin Medical University
Co-authored papers 3
Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 3
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Co-authored papers 3
Yuzhe Zhang
China University of Mining and Technology
Co-authored papers 3
Miranda Wang
Princess Margaret Cancer Center/University Health Network
Co-authored papers 3
Yi Liang
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Clifford A Meyer
Co-authored papers 2
Myles Brown
Co-authored papers 2
Robert G Bristow
University of Toronto
Co-authored papers 2
Kim N Chi
University of British Columbia
Co-authored papers 2
Martin E Gleave
University of British Columbia
Co-authored papers 2
Bo Zhang
Novel Bioinformatics Co.
Co-authored papers 2
Yasheng Zhu
Changhai Hospital, Naval Military Medical University
Co-authored papers 2
Release 1.2